[3P-0513] Convergent use of phosphatidic acid for Hepatitis C virus and SARS-CoV-2 replication organelle formation

^○Keisuke Tabata¹, Vibhu Prasad¹, David Paul¹, JiYoung Lee¹, MinhTu Pham¹, Twu WoanIng¹, Christopher Neufeldt¹, Mirko Cortese¹, Berati Cerikan¹, Cong Si Tran¹, Christian Lüchtenborg², Philip V’kovski^{3, 4}, Katrin Hörmann⁵, André Müller⁵, Carolin Zitzmann⁶, Uta Haselmann¹, Jürgen Beneke⁷, Lars Kaderali⁶, Holger Erfle⁷, Volker Thiel^{3, 4}, Volker Lohmann¹, Giulio SupertiFurga^{5, 8}, Britta Brügger², Ralf Bartenschlager^{1, 9, 10} (1.Dept. of Infect. Dis., Heidelberg Univ., 2.BZH, Heidelberg Univ., 3.Inst. of Virol. Immunology, IVI, Bern, 4.Dept. of Infect. Dis. Pathobiology, Univ. of Bern, 5.CeMM, Vienna, 6.Inst. of Bioinfo. Univ. Med. Greifswald, 7.BioQuant, Heidelberg University, 8.Center for Physiology and Pharmacology, Med. Univ. of Vienna, 9.Div. Virus-Associated Carcinogenesis, German Cancer Research Center, 10.German Center for Infection Research, Heidelberg)

g . Infection / Virus(4 . Animal and Plant Physiology, and Diseases)